Smoking Clinical Trials
Find clinical trials for smoking. Search for smoking clinical trials in different cities and states across the United States.
Prehabilitation & Rehabilitation
Sponsor:
Palo Alto Veterans Institute for Research
Location:
Code:
NCT06566976
Conditions
Peripheral Arterial Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Exercise Intervention
VAPAHCS Rehabilitation Core Components
Cardiovascular Intervention
Sponsor:
McMaster University
Location:
Code:
NCT03127631
Conditions
Prostate Cancer
Cardiovascular Disease
Eligibility Criteria
Sex: Male
Age: 45+
Healthy Volunteers: Not accepted
Interventions
Nutrition
Exercise
Smoking cessation
Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)
ACE inhibitor
What are smoking clinical trials?
Smoking clinical trials are research studies focused on understanding and addressing the effects of smoking, nicotine dependence, and methods for smoking cessation. These trials explore a variety of interventions, including electronic cigarettes, behavioral therapies, pharmacological treatments, and digital media campaigns, aimed at reducing smoking rates, preventing tobacco-related diseases, and mitigating the health risks associated with smoking.
Importance of clinical trials for smoking
Clinical trials for smoking are critical for developing effective strategies to combat nicotine addiction and reduce the public health burden of smoking-related illnesses. These studies provide valuable insights into the mechanisms of addiction, the efficacy of cessation methods, and the impact of smoking on various health conditions. By participating in smoking clinical trials, individuals can contribute to advancements in smoking cessation therapies and public health initiatives aimed at creating smoke-free communities.
Types of interventions studied in smoking clinical trials
Smoking clinical trials investigate a wide array of interventions to help individuals quit smoking or reduce their tobacco consumption. These interventions aim to address both the physical addiction to nicotine and the behavioral aspects of smoking. Some common types of interventions studied in smoking clinical trials include:
Nicotine replacement and pharmacological therapies
Trials often assess the effectiveness of nicotine replacement products, such as patches and electronic cigarettes, and medications that aid in smoking cessation to determine their impact on nicotine dependence and withdrawal symptoms.
Behavioral and educational programs
These research studies evaluate in-person and virtual smoking cessation programs, including cognitive behavioral therapy and peer-motivation strategies. These studies may focus on identifying triggers for smoking, building coping skills, setting quit goals, and providing support and encouragement.
Digital and media interventions
With the rise of digital health technologies, smoking cessation trials may explore the use of mobile apps, text messaging programs, online platforms, and wearable devices to deliver smoking cessation interventions remotely. The main focus of these trials is to focus on the use of digital media, including anti-vaping and anti-smoking advertising, and avatar-led therapeutic applications, to influence smoking behaviors and attitudes towards tobacco use.
Environmental and policy approaches
Smoking clinical trials may also examine the impact of policy changes and environmental interventions on smoking behavior and tobacco use prevalence. Examples include smoke-free policies in public spaces, tobacco taxes, graphic warning labels on cigarette packages, and community-based tobacco control programs.
Eligibility and participation in smoking clinical trials
Eligibility for smoking clinical trials varies, with studies targeting specific demographics, smoking behaviors, and health conditions related to tobacco use. Trials may be open to both current smokers wishing to quit and individuals affected by secondhand smoke. Criteria often include age, smoking history, and the presence of smoking-related health issues.
What to expect when participating in a smoking clinical trial
Participants in smoking clinical trials can expect a screening process to determine eligibility, detailed information about the study's purpose and interventions, and ongoing support and monitoring throughout the trial. This may involve using cessation products, attending therapy sessions, completing questionnaires, and participating in follow-up assessments to evaluate the intervention's effectiveness.
Explore our comprehensive guide to learn more about why people choose to volunteer and the impact you can make in advancing medical research. Discover the process of volunteering, what to consider before applying and the potential benefits and risks involved.
How to enroll in a clinical trial for smoking
Enrolling in a smoking clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.